Using wearable sensors during clinical tests may help doctors objectively measure changes in mobility in people with SBMA, a ...

Salanersen, a new Biogen treatment for SMA, was awarded breakthrough therapy status by the U.S. Food and Drug Administration. This potent therapy, similar to Spinraza, requires fewer doses (once ...

Combining genetic tests may better define complex SMN gene changes in SMA, including SMN2 copy numbers and hybrid structures.

Extracellular vesicles (EVs) are potential biomarkers for SMA progression and Spinraza treatment response. Untreated SMA patients show elevated EV levels, which decrease with Spinraza therapy.

Columnist Jasmine Ramos has found dating with a disability to be frustrating and emotionally exhausting, but she holds on to ...

This article was provided by our partner, the Muscular Dystrophy Association. It has been reviewed by Bionews for accuracy ...

Researchers used long-read sequencing to find two previously unknown SMN1 deletions in two women with mild adult-onset SMA.

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Note: This column describes the author’s own experiences with ...

Disease-modifying therapies can help children with SMA types 1 and 2 maintain a healthy weight and prevent stunted growth, a study suggests. Treated SMA type 1 children show improved nutrition and ...

Australia and New Zealand developed SMA newborn screening guidelines for early diagnosis and management. Screening involves testing dried blood spots for the SMN1 gene mutation and SMN2 copy number.

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google U.K. guidance recommends earlier, consistent monitoring for hip ...

A new high-dose Spinraza regimen is approved for SMA, with safety findings broadly consistent with the original 12 mg regimen. An SMA expert says patients already taking Spinraza may discuss switching ...